Bullish
Profit surges as agilon health (NYSE: AGL) raises 2026 revenue and EBITDA targets
Agilon Health (NYSE: AGL) reported a stronger Q1 2026 with net income surging to $48.9 million and Adjusted EBITDA reaching $53.8 million, despite a 7...